This study investigated patient adherence and persistence with trifluridine/tipiracil combination and regorafenib regimens for metastatic colorectal cancer, and also addressed whether sequence of administration had an effect on patient adherence and persistence to the therapies.
Panel issues weak recommendations for options in adults aged 50 to 79 years with no prior screening.
A large, prospective, observational study seeks to assess the real-world outcomes of people who use the at-home colorectal cancer screening test Cologuard.
Mortality risk drops 17 percent with one colonoscopy before diagnosis, 45 percent with three colonoscopies.
A retrospective analysis of more than 7000 patients found a potential association between colorectal cancer, hepatic metastasis, and chronic HBV status.
One finding was a drop in concordance rate for clonal alterations when NGS was performed on tumor tissue and ctDNA samples collected following treatment initiation.
Adherence to the 2018 WCRF/AICR recommendations as measured by a multicomponent “lifestyle score” was associated with a statistically significant decreased risk of CRC in men.
Model shows high-intensity surveillance could provide modest, clinically relevant benefits at acceptable cost.
Survey results show level of concordance between patients with CRC and their caregivers when rating care quality. The survey also measured whether clinical or demographic factors influenced the agreement between patient-caregiver pairs.
According to this prospective study, the lifetime risk of cancer in men with a pathogenic germline MSH6 alteration is relatively low.
